Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer

Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer: A Single-centre Retrospective Propensity Matched Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07099105

Acronym

SP vs MP robot

Enrollment

339

Registered

2025-08-01

Start date

2017-01-01

Completion date

2024-12-31

Last updated

2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Small Cell Lung Cancer

Brief summary

The goal of this observational study is compared the perioperative outcomes of robotic lobectomy using the SP system via the subcostal approach with those of multi-port robotic lobectomy using the Xi system via the intercostal approach.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients aged \> 18 years who underwent RATS lobectomy for NSCLC at the Korea University Guro Hospital between January 2017 and December 2024

Exclusion criteria

* patients who underwent Viedo-assisted thoracic surgery lobectomy * patients who underwent robotic lobectomy with other combined surgery * patients who received neoadjuvant therapy

Design outcomes

Primary

Measure	Time frame	Description
Postoperative pain	Postoperatively day 0,1,2,3	Postoperative pain using visual analog scale (minimum =0, maximum=10), A lower value reflects a lesser degree of pain perception (lower scores mean a better outcome)

Secondary

Measure	Time frame	Description
chest tube duration	Perioperative	Chest tube duration refers to the number of days a thoracic drain remains in situ following pulmonary surgery. The duration is measured in days (minimum: 1, maximum: no defined). Lower scores indicate a better outcome.

Countries

South Korea

Outcome results